$1.29
2.27% today
Nasdaq, Apr 04, 09:47 pm CET
ISIN
US58464J1051
Symbol
CCLD
Sector
Industry

Medical Transcription Billing Corp. Target price 2025 - Analyst rating & recommendation

Medical Transcription Billing Corp. Classifications & Recommendation:

Buy
50%
Hold
50%

Medical Transcription Billing Corp. Price Target

Target Price $4.17
Price $1.32
Potential
Number of Estimates 3
3 Analysts have issued a price target Medical Transcription Billing Corp. 2026 . The average Medical Transcription Billing Corp. target price is $4.17. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 1 Analysts recommend Medical Transcription Billing Corp. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medical Transcription Billing Corp. stock has an average upside potential 2026 of . Most analysts recommend the Medical Transcription Billing Corp. stock at Buy or hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 110.84 112.10
5.31% 1.14%
EBITDA Margin 23.37% 23.84%
113.20% 2.02%
Net Margin -4.11% 1.64%
92.81% 139.93%

3 Analysts have issued a sales forecast Medical Transcription Billing Corp. 2025 . The average Medical Transcription Billing Corp. sales estimate is

$112m
Unlock
. This is
1.14% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$113m 2.00%
Unlock
, the lowest is
$111m 0.14%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $111m 5.31%
2025
$112m 1.14%
Unlock
2026
$119m 5.83%
Unlock

3 Analysts have issued an Medical Transcription Billing Corp. EBITDA forecast 2025. The average Medical Transcription Billing Corp. EBITDA estimate is

$26.7m
Unlock
. This is
4.15% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$27.4m 6.84%
Unlock
, the lowest is
$26.1m 1.71%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $25.9m 101.87%
2025
$26.7m 3.19%
Unlock
2026
$29.8m 11.44%
Unlock

EBITDA Margin

2024 23.37% 113.20%
2025
23.84% 2.02%
Unlock
2026
25.11% 5.33%
Unlock

3 Medical Transcription Billing Corp. Analysts have issued a net profit forecast 2025. The average Medical Transcription Billing Corp. net profit estimate is

$1.8m
Unlock
. This is
156.58% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.1m 164.88%
Unlock
, the lowest is
$1.6m 150.12%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-4.6m 93.19%
2025
$1.8m 140.41%
Unlock
2026
$3.3m 79.89%
Unlock

Net Margin

2024 -4.11% 92.81%
2025
1.64% 139.93%
Unlock
2026
2.79% 70.12%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.28 0.11
93.19% 139.29%
P/E 11.65
EV/Sales 0.48

3 Analysts have issued a Medical Transcription Billing Corp. forecast for earnings per share. The average Medical Transcription Billing Corp. EPS is

$0.11
Unlock
. This is
155.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.13 165.00%
Unlock
, the lowest is
$0.10 150.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.28 93.19%
2025
$0.11 139.29%
Unlock
2026
$0.20 81.82%
Unlock

P/E ratio

Current -6.76 2,314.29%
2025
11.65 272.34%
Unlock
2026
6.49 44.29%
Unlock

Based on analysts' sales estimates for 2025, the Medical Transcription Billing Corp. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.49 88.46%
2025
0.48 1.35%
Unlock
2026
0.46 5.50%
Unlock

P/S ratio

Current 0.50 215.59%
2025
0.50 1.13%
Unlock
2026
0.47 5.52%
Unlock

Current Medical Transcription Billing Corp. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Roth MKM
Locked
Locked
Locked Mar 14 2025
Benchmark
Locked
Locked
Locked Nov 15 2024
Benchmark
Locked
Locked
Locked Aug 27 2024
Analyst Rating Date
Locked
Roth MKM:
Locked
Locked
Mar 14 2025
Locked
Benchmark:
Locked
Locked
Nov 15 2024
Locked
Benchmark:
Locked
Locked
Aug 27 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today